vs

Side-by-side financial comparison of CLARIVATE PLC (CLVT) and eXp World Holdings, Inc. (EXPI). Click either name above to swap in a different company.

eXp World Holdings, Inc. is the larger business by last-quarter revenue ($1.2B vs $617.0M, roughly 1.9× CLARIVATE PLC). CLARIVATE PLC runs the higher net margin — 0.5% vs -1.1%, a 1.6% gap on every dollar of revenue. On growth, eXp World Holdings, Inc. posted the faster year-over-year revenue change (8.5% vs -6.9%). CLARIVATE PLC produced more free cash flow last quarter ($89.2M vs $11.9M). Over the past eight quarters, eXp World Holdings, Inc.'s revenue compounded faster (12.4% CAGR vs -0.3%).

Clarivate Plc is a British-American publicly traded analytics company that operates a collection of subscription-based services, in the areas of bibliometrics and scientometrics; business and market intelligence, and competitive profiling for pharmacy and biotech, patents, and regulatory compliance; trademark protection, and domain and brand protection. Clarivate calculates the impact factor of scientific journals, using data from its Web of Science product family, that also includes services...

eXp World Holdings, Inc. is a global cloud-based real estate services provider. It operates the eXp Realty brokerage network, leverages immersive virtual 3D campus environments to support agent collaboration and operations, serves residential and commercial real estate markets across over 20 countries, and offers complementary services including mortgage, title insurance and professional development resources for real estate practitioners.

CLVT vs EXPI — Head-to-Head

Bigger by revenue
EXPI
EXPI
1.9× larger
EXPI
$1.2B
$617.0M
CLVT
Growing faster (revenue YoY)
EXPI
EXPI
+15.5% gap
EXPI
8.5%
-6.9%
CLVT
Higher net margin
CLVT
CLVT
1.6% more per $
CLVT
0.5%
-1.1%
EXPI
More free cash flow
CLVT
CLVT
$77.3M more FCF
CLVT
$89.2M
$11.9M
EXPI
Faster 2-yr revenue CAGR
EXPI
EXPI
Annualised
EXPI
12.4%
-0.3%
CLVT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLVT
CLVT
EXPI
EXPI
Revenue
$617.0M
$1.2B
Net Profit
$3.1M
$-12.9M
Gross Margin
66.8%
Operating Margin
6.7%
-1.1%
Net Margin
0.5%
-1.1%
Revenue YoY
-6.9%
8.5%
Net Profit YoY
101.6%
-35.7%
EPS (diluted)
$0.00
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLVT
CLVT
EXPI
EXPI
Q4 25
$617.0M
$1.2B
Q3 25
$623.1M
$1.3B
Q2 25
$621.4M
$1.3B
Q1 25
$593.7M
$954.9M
Q4 24
$663.0M
$1.1B
Q3 24
$622.2M
$1.2B
Q2 24
$650.3M
$1.3B
Q1 24
$621.2M
$943.1M
Net Profit
CLVT
CLVT
EXPI
EXPI
Q4 25
$3.1M
$-12.9M
Q3 25
$-28.3M
$3.5M
Q2 25
$-72.0M
$-2.3M
Q1 25
$-103.9M
$-11.0M
Q4 24
$-191.8M
$-9.5M
Q3 24
$-65.6M
$-8.5M
Q2 24
$-304.3M
$12.4M
Q1 24
$-75.0M
$-15.6M
Gross Margin
CLVT
CLVT
EXPI
EXPI
Q4 25
66.8%
Q3 25
65.0%
Q2 25
67.2%
Q1 25
65.1%
Q4 24
65.7%
Q3 24
66.2%
99.9%
Q2 24
67.2%
99.9%
Q1 24
64.9%
Operating Margin
CLVT
CLVT
EXPI
EXPI
Q4 25
6.7%
-1.1%
Q3 25
7.1%
0.3%
Q2 25
1.1%
-0.2%
Q1 25
-3.5%
-1.1%
Q4 24
-9.4%
-1.0%
Q3 24
3.5%
-0.7%
Q2 24
-36.9%
1.4%
Q1 24
0.8%
-1.9%
Net Margin
CLVT
CLVT
EXPI
EXPI
Q4 25
0.5%
-1.1%
Q3 25
-4.5%
0.3%
Q2 25
-11.6%
-0.2%
Q1 25
-17.5%
-1.2%
Q4 24
-28.9%
-0.9%
Q3 24
-10.5%
-0.7%
Q2 24
-46.8%
1.0%
Q1 24
-12.1%
-1.7%
EPS (diluted)
CLVT
CLVT
EXPI
EXPI
Q4 25
$0.00
$-0.08
Q3 25
$-0.04
$0.02
Q2 25
$-0.11
$-0.01
Q1 25
$-0.15
$-0.07
Q4 24
$-0.27
$-0.06
Q3 24
$-0.09
$-0.06
Q2 24
$-0.46
$0.08
Q1 24
$-0.14
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLVT
CLVT
EXPI
EXPI
Cash + ST InvestmentsLiquidity on hand
$329.2M
$124.2M
Total DebtLower is stronger
$4.3B
Stockholders' EquityBook value
$4.8B
$242.8M
Total Assets
$11.1B
$442.5M
Debt / EquityLower = less leverage
0.89×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLVT
CLVT
EXPI
EXPI
Q4 25
$329.2M
$124.2M
Q3 25
$318.7M
$112.8M
Q2 25
$362.6M
$94.6M
Q1 25
$354.0M
$115.7M
Q4 24
$295.2M
$113.6M
Q3 24
$388.5M
$130.4M
Q2 24
$376.4M
$108.4M
Q1 24
$361.8M
$109.2M
Total Debt
CLVT
CLVT
EXPI
EXPI
Q4 25
$4.3B
Q3 25
$4.4B
Q2 25
$4.5B
Q1 25
$4.5B
Q4 24
$4.5B
Q3 24
$4.6B
Q2 24
$4.6B
Q1 24
$4.6B
Stockholders' Equity
CLVT
CLVT
EXPI
EXPI
Q4 25
$4.8B
$242.8M
Q3 25
$4.9B
$235.3M
Q2 25
$5.0B
$218.4M
Q1 25
$5.0B
$212.0M
Q4 24
$5.1B
$204.9M
Q3 24
$5.5B
$211.1M
Q2 24
$5.6B
$220.3M
Q1 24
$5.9B
$222.4M
Total Assets
CLVT
CLVT
EXPI
EXPI
Q4 25
$11.1B
$442.5M
Q3 25
$11.2B
$458.7M
Q2 25
$11.4B
$481.2M
Q1 25
$11.5B
$435.8M
Q4 24
$11.5B
$390.7M
Q3 24
$12.0B
$432.6M
Q2 24
$12.1B
$457.4M
Q1 24
$12.5B
$426.7M
Debt / Equity
CLVT
CLVT
EXPI
EXPI
Q4 25
0.89×
Q3 25
0.90×
Q2 25
0.90×
Q1 25
0.90×
Q4 24
0.88×
Q3 24
0.84×
Q2 24
0.83×
Q1 24
0.79×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLVT
CLVT
EXPI
EXPI
Operating Cash FlowLast quarter
$159.9M
$13.8M
Free Cash FlowOCF − Capex
$89.2M
$11.9M
FCF MarginFCF / Revenue
14.5%
1.0%
Capex IntensityCapex / Revenue
11.5%
0.2%
Cash ConversionOCF / Net Profit
51.58×
TTM Free Cash FlowTrailing 4 quarters
$365.3M
$109.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLVT
CLVT
EXPI
EXPI
Q4 25
$159.9M
$13.8M
Q3 25
$181.1M
$28.9M
Q2 25
$116.3M
$36.1M
Q1 25
$171.2M
$39.8M
Q4 24
$141.3M
$13.7M
Q3 24
$202.9M
$46.0M
Q2 24
$126.2M
$71.1M
Q1 24
$176.2M
$60.7M
Free Cash Flow
CLVT
CLVT
EXPI
EXPI
Q4 25
$89.2M
$11.9M
Q3 25
$115.5M
$26.6M
Q2 25
$50.3M
$33.3M
Q1 25
$110.3M
$37.3M
Q4 24
$59.1M
$11.6M
Q3 24
$126.3M
$44.4M
Q2 24
$60.3M
$69.7M
Q1 24
$111.8M
$59.3M
FCF Margin
CLVT
CLVT
EXPI
EXPI
Q4 25
14.5%
1.0%
Q3 25
18.5%
2.0%
Q2 25
8.1%
2.5%
Q1 25
18.6%
3.9%
Q4 24
8.9%
1.1%
Q3 24
20.3%
3.6%
Q2 24
9.3%
5.4%
Q1 24
18.0%
6.3%
Capex Intensity
CLVT
CLVT
EXPI
EXPI
Q4 25
11.5%
0.2%
Q3 25
10.5%
0.2%
Q2 25
10.6%
0.2%
Q1 25
10.3%
0.3%
Q4 24
12.4%
0.2%
Q3 24
12.3%
0.1%
Q2 24
10.1%
0.1%
Q1 24
10.4%
0.1%
Cash Conversion
CLVT
CLVT
EXPI
EXPI
Q4 25
51.58×
Q3 25
8.26×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
5.75×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLVT
CLVT

Academia Government Group$312.3M51%
Re Occurring Revenues$114.1M18%
Life Sciences And Healthcare Group$98.3M16%
Transactional Revenues$97.1M16%

EXPI
EXPI

North American Realty$1.1B96%
International Realty$42.2M4%

Related Comparisons